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The use of computed tomography in patients with gastrointestinal disease is increasing.
However, the triple-phase computed tomographic angiographic appearance of the canine small
intestine and the effects that phase of contrast enhancement and plane of reconstruction have on
the appearance of the small intestine have not been fully evaluated. The purposes of this study
were to investigate these effects on the appearance of the small intestinal wall. The minimal and
maximal small intestinal diameter, wall thickness, number of wall layers identified, and degree
of mucosal enhancement were recorded. The plane of reconstruction did not have any significant
effects on wall thickness, diameter, degree of mucosal enhancement, or number of wall layers
identified. There was a positive association between body weight and intestinal diameter. The
arterial phase demonstrated the greatest mucosal enhancement and number of wall layers
identified. The transverse plane was subjectively the most useful for evaluation of the small
intestines.
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CHAPTER I
INTRODUCTION
Introduction to canine small intestinal disease
Clinical signs referable to the canine gastrointestinal tract are one of the most common
presenting complaints to veterinary practitioners.1 Prior studies2–6 have demonstrated the
prevalence of gastrointestinal signs as a cause for presentation to veterinary practitioners ranges
from 1-17.8%. These clinical signs include, but are not limited to: vomiting, inappetence,
anorexia, hyporexia, weight loss, lethargy, abdominal pain/discomfort, melena, hematochezia,
and diarrhea. The cause of these clinical signs may be attributed to a singular disease process or
may be multifactorial in nature.7 There are a plethora of diseases that can affect the canine small
intestine. These include inflammatory etiologies, infectious etiologies, parasitic etiologies,
neoplastic etiologies, and pharmaceutical administration among others.7 With the population of
dogs presenting for clinical signs relatable to the gastrointestinal tract, the prevalence of chronic
enteropathies has been reported to be 0.9-2.9%.3,5,6
In canine patients, the term chronic enteropathy is used to describe a disease in which
mucosal inflammation is a hallmark feature and an etiologic agent is not identified.2,7 This term
encompasses a multitude of diseases including diet-, antibiotic-, and steroid- responsive
diseases.7 Of these, steroid-responsive diseases have been most commonly equated with
inflammatory bowel disease.7 There are a number of categories in which inflammatory bowel
disease can be further characterized, which are based on the predominant cell type present. These
1

categories include: lymphocytic-plasmocytic enteritis, which is the most common, followed by
eosinophilic enteritis, eosinophilic gastroenteritis, which occur less commonly, and lastly
granulomatous enteritis, which is rarely identified.7–9 The clinical signs and bloodwork
abnormalities commonly associated with inflammatory bowel disease (IBD), such as vomiting,
diarrhea, weight loss, hypocholesterolemia, hypocalcemia, and hypoalbuminemia, are
nondescript and can be found in a multitude of disease processes.7
As with the diagnosis of any disease process, a thorough and complete physical
examination is paramount to determining the most appropriate diagnostic steps. A complete
blood count and serum chemistry profile are also typically performed and provide
complementary diagnostic information to the physical examination, as well as, establish the
patient’s baseline status before more advanced diagnostics are obtained.
Regardless of the diagnostic work-up plan, diagnostic imaging is considered an integral
part of the workup for these patients. Typical imaging modalities that are available to determine
the cause of gastrointestinal disease include abdominal radiography, including positive and
negative contrast radiographic studies, ultrasonography, fluoroscopy, and computed tomography.
These modalities each have a number of advantages and disadvantages and a variable amount of
availability (depending up on cost) within general practitioner and referral hospitals.
Of these, ultrasonography is often considered an integral imaging modality in the
diagnostic work up of small intestinal disease as a large majority of diseases affecting the canine
gastrointestinal tract cause abnormalities that can be identified ultrasonographically.10–15 These
changes typically manifest ultrasonographically as hyperechoic speckling or striations/stranding
within the mucosal and muscularis layers, either segmental or diffuse thickening of portions of
the small intestinal wall, abdominal effusion, or complete loss of normal wall layering.10,13–17
2

Even though these changes can be readily identified on ultrasonography, there is no single
change that is characteristic of one disease process. It has been shown that dogs with small
intestinal inflammatory disease processes may present with a normal overall wall thickness.10,17–
19

However, hyperechoic striations within the mucosal layer that are oriented perpendicular to the

lumen are more commonly associated with protein-losing enteropathy than hyperechoic
striations oriented parallel to the lumen or pinpoint hyperechogenicities throughout the mucosal
layer.10,13,14
Furthermore, the diagnostic utility of ultrasound in achieving a diagnosis in
gastrointestinal disease has been evaluated in dogs with chronic vomiting and diarrhea.20,21 Leib
and colleagues demonstrated that abdominal ultrasonography provided vital or beneficial
diagnostic information that led to a correct diagnosis in 22.5% of cases which presented for
chronic vomiting.20 This study also showed that there are a number of patient factors which
increased the diagnostic utility of abdominal ultrasound in these cases. These factors include
increased age, greater number of vomiting episodes per week, presence of weight loss, a greater
percentage of lost body weight, and a final diagnosis of gastrointestinal lymphoma or gastric
adenocarcinoma. Leib and colleagues also concluded that in 9% of cases abdominal
ultrasonography was marginally useful for the final diagnosis. While in the remaining 68.5.% of
these cases, abdominal ultrasound did not provide information that changed the course of the
medical work up or management.
In a separate study21 performed by Leib and colleagues in dogs presenting for chronic
diarrhea, abdominal ultrasound provided vital or beneficial diagnostic information for a correct
diagnosis in 15% of cases.21 In this study, abdominal ultrasound was especially beneficial in
cases with weight loss, palpation of an abdominal or rectal mass, and a final diagnosis of GI
3

neoplasia. In 68% of cases with chronic diarrhea in this study, abdominal ultrasound did not
provide information that changed the diagnosis or management of the case; however, in 15% of
cases, findings from the ultrasound changed or altered the management of the case. In the
remaining 17% of cases within this study, abdominal ultrasonography was of questionable
benefit in the final diagnosis.21
While ultrasound may be employed in the diagnostic workup of dogs presenting for
gastrointestinal signs due to its ability to reliably differentiate the small intestinal wall layering10,
there are a number of factors that affect the diagnostic quality of the ultrasound examination.
These factors include patient preparation, obesity, body wall thickness, thoracic conformation,
hair coat color, type of probe used for examination, frequency of probe, training of the examiner,
and administration of certain medications.11,12,22–24 Due to these limitations, computed
tomography (CT) and more specifically, computed tomographic angiography (CTA), have been
used more recently to gain additional clinical information in the evaluation of abdominal
disease.25–27 The increased use of this imaging modality can be attributed to its increasing
availability, short image acquisition times, and increased contrast resolution compared with
radiography and ultrasound.25,28–31 Computed tomography of the canine abdomen has been
shown to be sensitive and specific in the diagnosis of multiple disease processes such as small
intestinal mechanical obstruction, extrahepatic portosystemic shunts, pancreatic insulinomas, and
hemoabdomen.25–28,32,33 However, one area in which computed tomography has not been
routinely investigated is in the evaluation of infiltrative diseases that affect the small intestines.
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Gross anatomy of the canine small intestine
The canine small intestine extends from the pylorus to the ileocolic orifice and is
approximately 3.5 times the length of the body.34 The canine small intestine is grossly divided
into three segments: the duodenum, jejunum, and ileum. The duodenum is the most orad portion
of the small intestine and in a normal dog is approximately 25 centimeters (or 10 inches) in
length.34 It begins at the level of the pyloroduodenal orifice. It runs a short distance cranially
before turning caudally at the cranial duodenal flexure.34 It the lies adjacent to the right
abdominal body wall, runs caudally and makes a U-shaped turn medially at the caudal duodenal
flexure, and runs obliquely cranially before terminating at the jejunum.10–12,34
The duodenum can be further subdivided into three parts: descending, transverse, and
ascending.34 The descending portion of the duodenum lies within the right cranial abdomen and
is in contact with the right lateral and medial liver lobes, the dorsolateral abdominal wall, right
lobe of the pancreas, right kidney, and large intestine.11,12,34,35 The descending duodenum
terminates at the caudal duodenal flexure.10,34 The transverse duodenum connects the descending
and ascending portions and lies caudal to the jejunum and ventral to the sixth lumbar vertebra.34
The ascending portion of the duodenum runs cranially and to the left and lies ventral to the
ureters, great abdominal vessels, and is near the descending colon. Its termination is the
duodenojejunal flexure.34
The jejunum is the longest segment of the small bowel and begins at the duodenojejunal
orifice and terminates at the ileum.34 This segment of small intestine is located caudoventral to
the stomach and ventral to the large intestine, duodenum, pancreas, and kidneys.11,12,34,35 The
jejunum takes a serpentine course through the abdomen and is surrounded by the greater
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omentum.11,12,34 Individual loops of jejunum are connected to each other by mesentery. The
vascular supply to the jejunum is located within the mesentery.34
The ileum is the shortest segment of the small intestine and terminates at the ileocolic
orifice. The ileum in a normal dog is approximately 15 cm in length and lies within the right
cranial abdominal quadrant, medial to the right kidney.11,12,34,35

Figure 1.1

Ventral to dorsal view of the location of the canine abdominal viscera

1. Denotes the liver. 2. Denotes the stomach. 3. Denotes the spleen. 4. Donates the duodenum
(descending portion). 5. Denotes the jejunum. 6. Denotes the urinary bladder. Adapted from
Miller’s Anatomy of the Dog 4th edition.
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Arterial supply to the canine small intestines
The vascular supply to the canine small intestines originates from the first two major
branches of the abdominal aorta: the celiac and cranial mesenteric arteries.34 The first major
branch of the abdominal aorta, the celiac artery, exits the ventral aspect of the abdominal aorta at
the level of the first lumbar vertebra and first lumbar intervertebral disc space.34,36 This artery
immediately branches into the left gastric, hepatic, and splenic arteries.34 The left gastric artery
courses cranioventrally and supplies the left lateral aspect of the lesser curvature of the stomach
and the caudal esophagus.34 The splenic artery supplies the spleen, as well as the left greater
curvature of the stomach. The hepatic artery courses cranioventrally, gives off 3-5 branches to
the liver and a single branch to the right lateral aspect of the lesser curvature of the stomach
(right gastric) before continuing on as the gastroduodenal. The gastroduodenal courses over the
dorsal surface of the pylorus and terminates as the right gastroepiploic and cranial
pancreaticoduodenal arteries. The cranial pancreaticoduodenal artery runs caudally medial to the
right lobe of the pancreas and supplies the orad portion of the descending duodenum before
anastomosing with the caudal pancreaticoduodenal artery.34
The second major branch of the abdominal aorta is the cranial mesenteric artery.34,36 This
artery is larger than the celiac artery and exits the ventral aspect of the abdominal aorta
approximately 5 mm caudal to the celiac artery and at the level of the first lumbar intervertebral
disc space and L2 vertebral body.34,36 The cranial mesenteric artery terminates into three
branches: a common trunk for the colic and ileocolic arteries, caudal pancreaticoduodenal artery,
and 12-15 jejunal arteries.34 The common colic trunk is the major vascular supply to the large
intestines and ileum. The ileocolic artery originates from the common trunk and supplies the
ascending colon, cecum, and ileum. This artery gives rise to the mesenteric ileal branch, which is
7

the major vascular supply to the terminal ileum. Additional vascular supply to the ileum is
supplied through the antimesenteric ileal branch of the cecal artery.34
The jejunum receives the vast majority of its blood supply from the jejunal arteries in the
form of jejunal arcades, which are direct branches from the cranial mesenteric artery.34 These
jejunal arteries form primary and secondary arcades by anastomosing with each other directly
adjacent to the intestinal wall.34,37 These arteries also give rise to the vasa recti, which are short,
irregular arteries that go directly into the intestinal wall and enter the mesenteric border in the
small intestine and antimesenteric border in the large intestines.34,37
Within the intestinal wall themselves there are two major arterial networks with the most
well developed being the subserous network.38 The subserousal network is well-developed in
veterinary species as compared to humans and is a component of the mural network.38 The mural
network is a direct extension of the terminating arteries and plexiform anastomoses and mostly
resides within the submucosa.34,37

8

Figure 1.2

Branching of the celiac and cranial mesenteric arteries (dorsal view)

Adapted from Miller’s Anatomy of the Dog 6th edition.

Figure 1.3

Branching of the abdominal aorta and cranial mesenteric artery (dorsal view)

Adapted from Miller’s Anatomy of the Dog 6th edition.
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Ultrasonographic appearance of the canine small intestine
In vivo the canine small intestine appears as five distinct ultrasonographic layers, which
demonstrate an alternating hyperechoic and hypoechoic pattern. These layers starting from the
most superficial and progressing to the deepest include the serosa, muscularis propria,
submucosa, mucosa, and mucosal surface.11,12,19,35 The ultrasonographic appearance has been
demonstrated to have good to great correlation with the histologic layering of the small
intestine.12,35,39,40 The ultrasonographic thickness has also been shown to have good correlation
with that identified on histology.19,40
The normal ultrasonographic thickness of the different segments of the gastrointestinal
tract and a positive correlation of the thickness with body weight have been identified and
described in dogs.11,12,41 Dogs with body weights under 20 kilograms have a jejunal wall
thickness of ≤4.1 mm, dogs between 20 and 39.9 kilograms have a thickness of ≤4.4 mm, and
dogs over 40 kilograms having a thickness of ≤ 4.7 mm.41 The duodenal wall thickness of normal
dogs has also been described and a positive correlation with body weight identified.41 In this
study, normal dogs without clinical signs of gastrointestinal disease under 20 kilograms had a
thickness of ≤5.1 mm, dogs between 20 and 29.9 kilograms had a thickness ≤5.3 mm, and dogs
over 30 kilograms had a thickness of ≤6.0mm.41 Additionally, age has been identified as having a
significant effect on duodenal and jejunal wall thickness, with puppies having a thicker duodenal
wall and thinner gastric wall. The wall layering in normal puppies without clinical signs
associated with the gastrointestinal tract is also varied from that of adult dogs, with the mucosal,
submucosal, muscularis all being of equal thicknesses.11,12,39 In the adult, the mucosal layer is of
equal to the combined thicknesses of the submucosa, muscularis, and serosa.11,12
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Ex vivo studies of the canine small intestine have identified two additional
ultrasonographic layers: a hyperechoic line within the muscularis layer and a dual echogenic
mucosal layer.19 Histologically, the hyperechoic line within the muscularis layer was shown to
correlate with the junction of the muscularis longitudinal and circular layers, while the dual
echogenicity of the mucosal layer was attributed to the intestinal villi and lamina propria.19

Figure 1.4

Ultrasonographic demonstration of normal wall layering in the descending
duodenum (long axis)

Demonstration of normal wall layering. Note the alternating hyperechoic and hypoechoic layers.
Adapted from Small Animal Diagnostic Ultrasound 3rd edition.

Figure 1.5

Ultrasonographic demonstration of the normal wall layering of the descending
duodenum (short axis)

Demonstration of normal wall layering. Note the alternating hyperechoic and hypoechoic layers.
Adapted from Small Animal Diagnostic Ultrasound 3rd edition.
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Contrast enhanced ultrasonography of the canine small intestine
The evaluation of the canine small intestine using contrast enhanced ultrasonography is
limited to four studies.42–45 Two studies42,43 evaluated the small intestines in normal dogs, while
two other studies44,45 evaluated the small intestines in abnormal dogs. Of the two studies
involving normal dogs, one43 evaluated the duodenum in eight healthy normal client owned
Beagle dogs and the remaining study42 evaluated the jejunum in nine healthy client owned dogs.
Of the two studies44,45 evaluating the small intestine in abnormal dogs, only one45 looked at
diseases that pertain to this discussion and thus this is the only study that will be discussed.
Normal duodenum
In a study43 performed by Johnson-Neitman and colleagues, the duodenum in a set of
eight healthy client owned dogs was evaluated using a right intercostal approach. After
administration of a microbubble contrast agent1, the microbubbles were first identified in the
cranial pancreaticoduodenal artery. This was followed by a simultaneous contrast inflow and
enhancement of the pancreatic parenchyma and serosal and mucosal layers of the duodenum.
Peak intensity of the duodenal layers occurred after this and was characterized by homogeneous
simultaneous enhancement of all of the duodenal layers. The contrast agent arrived at the
duodenum approximately 6.95 ± 2.91 seconds following administration, the time to peak
enhancement of the duodenum occurred at 13.08 ± 6.16 seconds following administration, and
the outflow rate was -1.81 ± 1.62 decibels/second. These values were not statistically significant
than those obtained for the pancreas.

1

Definity, Bristol-Myers Squibb Medical Imaging, New York, New York
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Normal jejunum
In a study42 performed by Jiménez and colleagues, the contrast enhancement pattern in
the jejunum in a set of nine client owned healthy dogs was described. In this study three serial
doses of a microbubble agent were utilized in an incrementally, escalating dose protocol (0.007
ml/kg, 0.015 ml/kg, and 0.03 ml/kg). In this study the mean time to peak for each of these values
were: 14.1, 19.6, and 21.9 seconds after contrast administration respectively. Peak intensity
values for these doses were 38.3, 58, and 79.2 mean pixel values, respectively. In this study, the
high dose subjectively revealed the clearest delineation of the jejunal arteries and enhancement
of the jejunal wall. The enhancement of the jejunal wall occurred in a serosal to luminal direction
and contrast enhancement was subjectively unsatisfactory in 77% of dogs with low dosing.
Abnormal canine small intestine
In a study45 by Nisa et al, 47 client owned dogs with gastrointestinal signs and
histopathology of the duodenum were enrolled and categorized into three separate groups: dogs
with a histopathologically normal duodenum, which was used as a control group(14 dogs),
chronic inflammatory enteropathy (26 dogs), and intestinal lymphoma (7 dogs). Dogs with
chronic inflammatory enteropathy (CIE) were further subdivided into those that were in
remission (16 dogs) and those that were symptomatic (10 dogs). A microbubble contrast agent2
was administered intravenously at a dose of 0.01 ml/kg in all dogs. This study found that the
peak intensity was significantly higher in dogs with symptomatic CIE than the control group,
105.4 mean pixel value and 89.9 mean pixel value respectively. The peak intensity in this study
also positively correlated with the canine chronic enteropathy clinical activity index score of the

2

Sonazoid®, GE Healthcare, Oslo, Norway
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CIE group. The area under the curve was also significantly higher in symptomatic CIE dogs
compared to the control group and those in remission. No significant differences were observed
between the CIE group and the lymphoma group for any of the parameters evaluated.
Computed tomographic appearance of the canine small intestine
There are currently only four papers46–49 that describe the appearance of the normal
canine small intestines using contrast enhanced computed tomography.
In a study46 performed by Hoey and colleagues, the appearance of the canine
gastrointestinal tract was reported following the administration of a nonionic, iodinated contrast
agent at 300 mg I/kg of patient body weight. In this study of healthy dogs, 62.8% of
gastrointestinal segments were identified from serosa to serosa, while 77.7% of gastrointestinal
walls were identified from serosa to mucosa on precontrast series. After administration of
intravenous contrast, individual wall layering was identified in 21.8% of these intestinal
segments when utilizing single phase angiography, with the majority of the wall layering being
identified within the stomach and jejunum.
In a separate study47 performed by Fitzgerald and colleagues, the appearance of the
gastrointestinal tract using dual phase angiography (including portal and delayed venous phases)
and normal attenuation value of the small intestinal mucosa during the portal phase of
enhancement in healthy dogs was described. Fitzgerald and colleagues found that the
gastrointestinal wall (serosa to mucosa) could be identified in 56.7% of segments prior to
contrast administration, 84.5% of segments during the portal phase of enhancement, and 77.3%
of segments during a late phase of enhancement. In this study, the enhancement of the mucosa
was identified as being between 43-150 HU. Fitzgerald and colleagues concluded that, the portal
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phase of enhancement was described as being the best phase for mucosal enhancement during
this study.
A separate study49 by Keh and colleagues, evaluated the clinical utility of computed
tomographic enterography. In people, contrast enhanced computed enterography has been
utilized to evaluate the gastrointestinal tract for inflammatory bowel disease.50 This is a
procedure in which1.0 – 1.5 liters polyethylene glycol solution or 0.1% barium sulphate and
water-methylcellulose solution is administered orally 45-60 minutes prior to CT.50 Keh and
colleagues administered a 1:4 lactulose: water solution at a dose of 60 mL/kg as either a bolus or
slowly over 45 minutes.49 Noncontrast enhanced CT studies were then performed every 10
minutes for 1 hour. The constant infusion over 45 minutes resulted in good luminal distension of
all intestinal segments, with the optimal distension occurring between 0 and 20 minutes.
The most recent paper48 by Lee and colleagues identified the time of enhancement in
which the arteries supplying the gastrointestinal tract could be identified the best and in which
phase the wall of the gastrointestinal tract enhanced the most. In this study, a new phase of
enhancement was identified and was termed the intestinal phase, which was defined as occurring
at approximately 38.9 seconds after the administration of intravenous contrast. This study was
performed by use of a small test-bolus and calculating time-to-attenuation curves of the major
abdominal aorta and cranial mesenteric artery. This study found that the gastrointestinal wall
enhancement was greatest during the intestinal phase and venous phases, with the attenuation
values being 49.76 and 46.68 HU respectively. This study also found that there was no
significant difference between these two phases in regards to degree of enhancement. This study
did, however, identify a difference in the enhancement pattern between these two phases, with
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the mucosal layer being predominately enhanced in the intestinal phase and transmural
enhancement being predominant in the venous phase.
Computed tomographic contrast agents
Ioversol
There are a number of nonionic, iodinated contrast agents, available for use in veterinary
medicine, of which Iohexol3 and Ioversol4 are two of the most commonly used and readily
available intravenous contrast agents. These agents are non-ionic, tri-iodinated, monomeric
contrast medium that are water soluble. At the author’s institution, the most commonly used
agent is Ioversol, therefore the following discussion will be limited to this contrast agent.
Ioversol contains 47.2% organically bound iodine and has a molecular weight of 807.11.
The typical dose for Ioversol is based upon the age of the patient, patient body weight, and study
being performed. At the author’s institution, this contrast agent is most commonly used for
procedures involving the nervous and musculoskeletal systems, thoracic cavity, and abdominal
cavity, and is administered at a dose of 700-704 mg of iodine per kilogram of body weight
(approximately one milliliter of Optiray 320 per pound of body weight). After administration,
Ioversol demonstrates an open two-compartment model with first order elimination.
According to the pharmacokinetic data provided by the manufactor51, there is an initial,
rapid alpha phase in which the drug is distributed systemically, which is then followed by a
slower beta phase in which the drug is eliminated. The biological half-life in human patients is
approximately 1.5 hours with the vascular compartment half-life being 20 minutes. Blood levels

3

Omnipaque, GE Healthcare, Oslo, Norway

4

Optiray, Liebel-Flarsheim Company LLC., Raleigh, North Carolina
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typically reach their peak immediately after injection and fall with 5-10 minutes. The main route
of excretion is through the kidneys and in humans greater than 95% of the administered dose is
excreted in the first 24 hours.51 The peak urine concentration typically occurs within the first two
hours; however, this excretion rate is dependent on both the dose delivered and renal function in
the patient. In humans, administration of larger doses of the agent resulted in shortened excretion
times.
According to the manufacturer 51, adverse reactions following the administration of
Ioversol are usually mild to moderate, occur for only a short duration of time, and resolve
without treatment or therapeutic intervention. The most common adverse effect following the
administration of Ioversol in humans is nausea, which occurs at a rate of greater than 1% in
patients.51 Other less common reactions have been noted and are included in the following table.
These reactions have been documented in less than 1% of people.
Contrast reactions in veterinary species
A number of studies have evaluated the prevalence of contrast induced reactions in
veterinary medicine.52–54 There are also a number of case reports that have been documented.55,56
In a study55 performed by Pollard and colleagues a reaction rate (defined as a change in heart rate
and blood pressure of 20%) of 7% after administration of iodinated, ionic contrast agents and 1%
after administration of non-ionic, iodinated contrast agents were reported. In the most recent
study53 performed by Scarabelli and colleagues, 18% of patients had a mild reaction (indicated
by a change in heart rate, respiratory rate, and mean arterial pressure of <10%), 18% experienced
a moderate contrast reaction (defined as a change in heart rate, respiratory rate, or mean arterial
pressure between 10-20%), and 1% of patients experienced a severe reaction (requiring
intervention).
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In veterinary patients, one of the most life-threating complications following
administration of intravenous iodinated contrast agents is the development of acute anaphylactic
reactions.52–55,57,58 Additional systemic reactions that have been reported include contrastinduced nephropathy, cardiovascular alterations, and respiratory alterations.52–54,57,58 The
pathogenesis of anaphylactic reactions after administration of contrast media is unclear, but has
been proposed to be due to the activation of the complement cascade. There have been a
multitude of proposed mechanisms as to the pathogenesis of nephrotoxicity following
administration of nonionic iodinated contrast agents. The two most prevailing theories include
renal vasoconstriction, which results in medullary hypoxemia, and the direct cytotoxic effect of
contrast media on renal tubular cells.58,59
A study60 by Davenport and colleagues using human patients identified that patients with
a serum creatinine of 1.6 g/dL or greater were at an increased risk of developing renal associated
acute kidney injury. This study also demonstrated an odds ratio of 1.26, meaning for every 1.0
g/dL that the patient’s serum creatinine levels rose above 1.5 g/dL the odds of developing acute
kidney injury following contrast administration increased by 1.26.60
A separate study 61, also identified that the risk of contrast induced nephrotoxicity in
humans increases with administration of a second dose of nonionic, iodinated contrast agents. In
this study, patients who maintained normal renal function after an initial contrast-enhanced
computed tomographic exam underwent a second contrast-enhanced computed tomographic
examination and significant elevations of serum creatinine and decreased in the estimated GFR
were identified, with four patients developing contrast induced nephropathy.
To date, there is only one publication reviewing contrast induced nephropathy (CIN) in
dogs.58 In this paper, CIN was defined as an increase in serum creatinine of 0.5 mg/dL from
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baseline within 1 week following the administration of IV contrast. The rate of CIN in this study
was found to be 7.6%, which mimics that which has been reported in the human literature of 0%
to 33%.58,62–64 The authors in this study did not identify a causal relationship between the
administration of intravenous contrast and the occurrence of CIN.58 In fact, none of the evaluated
parameters (patient signalment, initial creatinine levels, number of total contrast administrations,
dose of contrast received, duration of anesthesia, intravenous fluid administration, administration
of additional nephrotoxic agents, or use of vasopressor therapy) were found to be different
between the group that developed CIN following examination and those that did not.58
Inflammatory bowel disease in dogs
Pathogenesis of inflammatory bowel disease in dogs
Similar to that in humans, the exact mechanism of inflammatory bowel disease in dogs is
not entirely known; however, it is thought that complex interactions between the intestinal
microbes and dysregulated immune system responses occur within affected dogs.65,66 A potential
genetic predisposition has also been proposed and several dog breeds have been reported as
being predisposed to the development of certain types of IBD.9,67 Examples include proteinlosing enteropathy in Soft-Coated Wheaten Terriers, immunoproliferative enteropathy in
Basenjis, granulomatous colitis in Boxers, and lymphocytic-plasmacytic enteropathy in German
Shephard Dogs (GSD).9,17,67,68
Genetic sequencing has identified alterations in the expression of pattern recognition
receptors TLR4 and TLR5 in affected GSDs as compared to healthy Greyhound dogs.69 Further
studies investigated whether allelic variations of these pattern recognition receptors and that of
TRL2 contributed to the abnormal response of the intestinal microbiota. Multiple nonsynonymous single nucleotide polymorphisms (SNPs) were identified in the TLR5 and TRL4
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genes, which were significantly associated with the development of IBD in dogs. Both GSD and
non-GSD dogs with IBD also had alterations in the canine NOD2 gene, which suggests that these
mutations may contribute to the development of IBD through the development of chronic
mucosal inflammation.70 Furthermore, up-regulation of the TLR2, 4, and 9 pattern recognition
receptors has been identified in dogs with duodenal and colonic mucosal inflammation secondary
to IBD, suggesting that there is derangement of the patient’s innate immunity.71 The degree of
expression of TLR2 receptors has also been correlated to the clinically severity of disease in
affected dogs.72
Specific local immune cell populations demonstrate alterations in dogs affected by IBD.
These include an increase in the local concentration of lamina propria IgA+ and IgG+ plasma
cells, CD3+, CD4+, and CD8+ T cells, macrophages, and neutrophils and a decrease in the local
mast cell population.73–75 Mucosal cytokines profiles are also altered in affected dogs with mixed
Th1/Th2 activation.76–79 NFkB activation within the lymphocytes in the lamina propria of dogs
with IBD has also been documented. NFkB in humans has been shown to influence the
production of IL-23, which is related to mucosal inflammation, differentiation of novel CD4+,
and production of IL-17.9,80
The local microbiota have been shown to be an important contributor to the development
and progression of chronic enteropathies. In particular, the association of dysbiosis, an imbalance
or disruption of the GI microbiome, has been increasingly recognized and researched as of late.9
A connection between chronic inflammatory bowel disease and a change within the normal small
intestinal microbiota has shown that affected dogs have increased Enterobacteriaceae,
Clostridiaceae, and Escherichia coli bacteria attached either to the mucosal epithelia or invading
into the mucosa.9 This alteration has also been identified in other forms of chronic enteropathies
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and intestinal neoplasia. The number of bacteria adhered to the colonic mucosa has been
positively correlated with disease severity in dogs with IBD.68
Diagnosis of inflammatory bowel disease in dogs
The diagnosis of inflammatory bowel disease (IBD) is complex, and usually
involves synthesizing data from the patient’s signalment, history, physical exam findings,
diagnostic imaging, clinicopathologic testing, and histopathology of intestinal biopsies. The most
common presenting complaints for dogs with IBD include vomiting, diarrhea, and weight
loss.9,67 These can occur in isolation, in combination, or in addition to lethargy, inappetence,
tenesmus, melena, hematochezia, and peripheral edema.8 When the clinical presentation includes
diarrhea, every attempt must be made to characterize the diarrhea as small bowel or large bowel
diarrhea. Small bowel diarrhea is commonly associated with IBD. In dogs with diarrhea, a
diagnosis of IBD is typically considered after other etiologies have been excluded, such as
infectious and parasitic agents, non-GI disorders, exocrine pancreatic insufficiency, pancreatitis,
endocrinopathies (especially hypoadrenocorticism), and intestinal structural abnormalities.
Because IBD is a diagnosis of exclusion, the standard diagnostic approach includes complete
blood counts, serum chemistry, fecal analyses and floats, cobalamin and folate levels, screening
for hyperadrenocorticism, ultrasonography and radiography of the abdomen, treatment trials with
novel protein or hydrolyzed diets as well as endoscopy and histopathology if deworming and
dietary trials fail.
Diagnostic imaging of IBD
Although abdominal radiographs are an important part of the diagnostic work up of IBD,
they are limited in their evaluation of the small intestinal wall thickness due to the border
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effacement that occurs from the similar opacities of the intestinal wall and the intraluminal
ingesta. The degree of luminal distension and phase of peristalsis also play a role in limiting the
diagnostic value of abdominal radiographs. The addition of barium can help delineate the
thickness of the intestinal wall on radiographs. Findings that correlate with intestinal wall
thickening and IBD on positive contrast abdominal radiographs include a rapid passage of
contrast, a thickened wall, and an irregular mucosal margins.10,81 These findings, however, are
not pathognomonic for IBD and may be seen with a variety of disease.
As previously mentioned, ultrasonography is currently the imaging modality of choice for
small animal patients with IBD. Common ultrasonographic findings include diffuse, moderate
(<6 mm) intestinal wall thickening, hyperechoic mucosal striations/stranding/foci, retention of
normal wall layering, and mesenteric lymphadenopathy.10–14 These findings in combination with
the presence of hypoalbuminemia and/or hypocobalaminemia should warrant the consideration
of intestinal biopsies to confirm the presence of IBD. 8,10–12,16,17,40,82,83 Using imaging
characteristics to differentiate IBD from neoplasia or infectious etiologies can be challenging due
to an overlap of gross and visual changes.10–12 A prior study,82 has shown that the mean maximal
wall thickness in dogs with nonspecific enteritis was significantly less than those dogs with
intestinal neoplasms. However, in this study a small set of cases developed severe (>15 mm)
wall thickening that was attributed to enteritis. This study also demonstrated that severe focal
thickening (>15 mm) and loss of wall normal wall layering was more commonly associated with
neoplastic etiologies than inflammatory etiologies. Intra-abdominal lymphadenopathy was
reported in both populations within this study, but was more commonly identified and was more
severe in patients with intestinal neoplastic etiologies than those with inflammatory etiologies.82
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Other studies17,18, however, have shown that the wall thickness between dogs affected by
IBD and normal dogs is not significantly different. The authors in one of these studies18 proposed
that these dogs may have had disease that was sufficient to cause clinical signs, but not
infiltrative enough to cause ultrasonographic abnormalities. In the remaining study17, the authors
found that a novel ultrasound score that evaluated the wall thickness of the duodenum and
jejunum, mucosal echogenicity, lymph node size and appearance, and secondary changes was
correlated with activity of clinical disease at presentation but not after initiation of treatment.
Bloodwork, Intestinal Biopsy and Histopathology
The complete review of bloodwork derangements, intestinal biopsy procedures,
histopathologic appearance, and treatment for patients with IBD is beyond the scope of this
thesis. However, a short synopsis is provided. The presence of hypoalbuminemia and the levels
of folate and cobalamin can help direct the clinician to the need for intestinal biopsy, as well as,
localizing the site of gastrointestinal tract in which biopsies need to be obtained, as cobalamin is
preferentially absorbed in the ileum.7,8 These parameters can also help establish a
prognosis.8,9,17,67
Intestinal biopsies can be obtained either endoscopically or surgically. In some cases,
endoscopically is the preferred choice, especially since prior studies have shown that the
endoscopic appearance may correlate better with patient outcome than the histopathologic
appearance.8,84,85 Although, it has been inconsistently shown that endoscopic biopsies are less
sensitive in the diagnosis of IBD and/or concurrent lymphangiectasia than full thickness
biopsies.17 With adequate sampling of the duodenum and ileum, and adequate skill of the
endoscopist, biopsies obtained via endoscopy usually provide a diagnosis. New guidelines have
been published recently86 to maximize the usefulness of endoscopic pinch biopsies. Full
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thickness biopsies of the duodenum, jejunum, and ileum do allow more thorough evaluation of
the intestinal wall. However, the risk of surgical complications and dehiscence with
hypoalbuminemia and/or colonic biopsies makes endoscopic biopsies in these scenarios more
attractive to both clinicians and owners. Furthermore, IBD occurs in the mucosa, which is easily
obtained via endoscopy.
The most common histopathologic finding in IBD is increased cellularity of the lamina
propria. Both the degree and type of cellular accumulation can vary widely and can have a range
of categories from normal to severe. In the presence of a large number of macrophages and
neutrophils, infectious causes should be further pursued, while the presence of an increased
number of lymphocytes and plasma-cells or eosinophils is more consistent with lymphocyticplasmocytic enteritis or eosinophilic enteritis, respectively.8,67
Treatment of inflammatory bowel disease in dogs
Treatment of IBD in dogs is related to the underlying etiology and involves correcting
any nutritional abnormalities and counteracting inflammation and dysbiosis. Typically, the
cornerstone of treatment is considered to be the feeding of nutritionally balanced, highly
digestible elimination diet. Additional treatments include administration of immunosuppressive
doses of systemic glucocorticoids, other systemic immunosuppressive agents, and antibiotic
therapy.8,17,18,67 In some cases prebiotics and probiotics have also found to be beneficial.9,67
Human abdominal imaging
Traditionally, ultrasound was the primary imaging modality employed in the work up of
inflammatory bowel disease in humans for the last 20 years.87 This imaging modality has been
shown to have moderate to high sensitivity and specificity for the diagnosis of mural enteric
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inflammation caused by Chron’s disease (CD), ranging from 75-94% and 67-100%,
respectively.87 Ultrasound, also has been proved to be an excellent modality in the diagnosis of
strictures, identifying all strictures in a group of 22 patients and excluding strictures correctly in
10/11 patients.87 However, these values have been shown to be dependent not only on the
training of the operator, but also on the depth of the segment of bowel affected and the institution
in which the examination was performed.87,88
In people, the current gold standard modality for the diagnosis of Crohn’s Disease (CD)
is cross-sectional imaging, specifically computed tomography and magnetic resonance
imaging.87,88 Typically, the first choice for imaging of the human abdomen is computed
tomography or computed tomographic enterography due to its wide availability and quick
acquisition times. Computed tomography has also been shown to be both highly sensitive and
specific for mural enteric inflammation as well as for the diagnosis of small bowel stenosis,
intraabdominal fistulas, and intraabdominal abscesses.87,88 Perhaps the biggest disadvantage of
computed tomography is that it uses ionizing radiation and is a major contributor to the total
medical ionizing radiation dose a patient receives each year. Given that the age of diagnosis of
most patients with CD is young to middle aged, clinicians should be mindful of this dose and
subsequent doses of ionizing radiation in their patients.87 Because of the received dose of
ionizing radiation and the need for subsequent follow up imaging examinations, it has been
suggested that computed tomographic enterography be used as the initial imaging examination
for the diagnosis of CD with MRI being employed as a follow up and for recheck examination.87
Magnetic resonance imaging has also been shown to be highly sensitive and specific in
the diagnosis of CD and is comparable to CTE in the identification of enteric mural
inflammation and small intestinal stenosis.87 MRI has also been shown to be more accurate than
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other imaging modalities for the diagnosis of intraabdominal fistulas.87 One of the biggest
limitations of using MRI to evaluate the small intestines is motion artifact due to normal
peristaltic activity. Studies have shown that this artifact can be reduced by using heavily T2
weighted sequences that are optimized to decrease motion and improve depiction of the
perienteric mesentery.89 The administration of Butylbromide and glucagon have also been shown
to decrease the normal peristaltic activity prior to MRI evaluation.87,89 Other limitations of MRI
include lack of access, increased acquisition times, and increased time of image interpretation.87
Computed tomographic enterography (CTE) is typically performed as the prior imaging
modality when IBD is suspected, although in some cases magnetic resonance imaging
enterography (MRE) is considered an adequate alternative.87 When comparing the two
modalities, MRE and CTE were equally accurate for the assessment of enteroenteric fistulas;
however, MRE identified more intestinal strictures. Moreover, MRE has better agreement for
diagnosis of ileocolonic CD when compared to colonoscopy and CTE.87 Computed tomographic
enterography has been shown in a single study to be better able to distinguish perienteric
features, such as mesenteric hypervascularity, edema, fibrofatty proliferation, and
lymphadenopathy, better than MRE, while the two modalities have near agreement on the mural
features associated with CD such as wall thickening >3mm, and mural hyperenhancement.90
Future advancements and the addition of diffusion weighted imaging in MRI is likely to make to
this modality the gold standard for the diagnosis of CD in humans.87
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CHAPTER II
STUDY
Study Objectives
This study was performed with the following objectives:
1.

To describe the maximum and minimum diameter of the normal canine small intestine in

three groups of normal dogs, categorized by body weight during triple-phase computed
tomographic angiography (CTA).
2.

To describe the contrast enhancement pattern of the normal canine small intestine using

triple-phase CTA.
3.

To determine the relation between body weight and diameter of the normal canine small

intestine.
Hypotheses
1.

The arterial phase will be the most beneficial for evaluating the small intestinal mucosal

layer, due to the greatest degree of mucosal enhancement in this phase.
2.

Increasing body weight will be positively correlated with small intestinal diameter.

3.

Increasing body weight will be positively correlated with small intestinal wall thickness.

4.

Triple-phase CTA will be a reliable imaging modality to measure the normal canine

small intestinal diameter and wall thickness and will allow assessment of wall layering.
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Materials and Methods
Study population
Client owned dogs that were admitted to the primary small animal care services and were
undergoing contrast-enhanced computed tomography examinations for problems unrelated to the
gastrointestinal tract were prospectively recruited. Client consent for acquiring an additional
computed tomographic examination of the abdomen was obtained prior to inclusion. The
Institutional Animal Care and Use Committee (IACUC) approved this study prior to data
collection, and the study was conducted in accordance with the IACUC protocols.5 Inclusion
criteria was limited to triple-phase CTA of the entire abdomen, defined as the cranial extent of
the diaphragm to the coxofemoral joints, and a complete blood count and serum chemistry
profile with no evidence of abnormalities referable to the gastrointestinal tract as determined by
the attending clinician. Exclusion criteria included any clinical signs suggestive of
gastrointestinal disease within the last 24 hours, such as vomiting, diarrhea, or inappetence, any
history of exploratory laparotomy for suspected small intestinal disease (mechanical small
intestinal obstruction, infiltrative disease, etc.), or active pancreatitis. Further exclusion criteria
included a reported history of clinical signs related to the gastrointestinal tract within the last six
months, any episode of vomiting or diarrhea within the last 48 hours, a history of prior
laparotomy (excluding ovariohysterectomy procedures), or suspected pancreatitis (based on
clinical or physical examination parameters consistent with pancreatitis, a positive canine
pancreatic lipase immunoreactivity test, or abdominal ultrasound findings consistent with
pancreatitis).

5

IACUC-17-630
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Imaging
Subjects were sedated using a protocol chosen by the attending primary clinician. An
attempt was not made to standardize sedation protocols. Computed tomographic angiographic
examination using a Toshiba Aquilion 16-slice multi-detector row CT scanner6 was then
performed using the following technical parameters: 16 x 0.5 or 16 x 1.5 mm collimation, tube
rotation of 0.5 s, 100 or 120 kVp, variable mAs (range from 80-200 mAs), helical pitch of 1.5,
and a field-of-view large enough to encompass the entire circumference of the abdomen.
Positioning was based on the optimal positioning for the anatomic region of interest most
pertinent to the patient’s clinical signs. Examinations were performed as previously described.
25,27

Briefly, a pre-contrast scan was performed followed by injection of a non-ionic, organic,

iodinated contrast agent, Ioversol7 intravenously at a dose of 704 mg/kg body weight by a powerinjection system8 at a rate of 3 mL/seconds. The initial post-contrast scan was performed during
the later arterial phase, 25s after initiation of contrast injection. The portal and venous phase
scans followed at time intervals of 40s and 90s after initiation of injection. Once scanning was
completed, reconstruction of the image data using a soft tissue kernel was performed with a
variable slice thickness based on patient body weight (3mm for dogs <10kg and 5mm for dogs
>10kg) in transverse, dorsal, and sagittal imaging planes.

6

Toshiba Corporation, Toshiba American Medical Systems Inc., Tustin, California

7

Optiray 320 mg/mL, Liebel-Flarsheim Company, LLC, Raleigh, North Carolina

8

Medrad Stellant, Bayer Healthcare LLC, Whippany, New Jersey
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Measurements
Image evaluation was performed using the open-source digital imaging and
communication in medicine viewer, OsiriX 64-bit v.5.9.9 Window and leveling was allowed to
optimize the images based on evaluator preferences. The small intestinal diameter and wall
thickness was measured using electronic calipers. Measurements were performed on small
intestinal loops, as previously described46 in a study by Hoey and colleagues. In short,
measurements were acquired from small intestinal loops whose short axis was close to the plane
of evaluation, and whose shape was not being altered by adjacent abdominal structures.46 A
board-certified radiologist and a second-year diagnostic imaging resident measured and recorded
the maximum (Figure 2.1) and minimum (Figure 2.2) small intestinal diameter and wall
thickness in all three planes (transverse, sagittal, and dorsal) and all three phases of contrast
enhancement (arterial, portal, and venous).
The intestinal diameter was defined as the thickness from serosa to serosa, and intestinal
wall thickness was defined as the thickness from mucosa-luminal interface to serosa. The small
intestinal diameter and wall thickness were measured at one site in each of the following
locations: ascending duodenum, descending duodenum, transverse duodenum, ileum, and
ileocolic junction. These same measurements were obtained at three locations over the course of
the jejunum. Distinction of individual wall layers was scored using a scale in which the number
of wall layers identified corresponded with the numerical value recorded (0 given when no
distinct layers are identified, 1 being only 1 layer identified, 2 being 2 distinct layers identified, 3
being 3 distinct layers identified, and 4 being each individual layer identified).

9

Pixmeo SARL, Geneva, Switzerland
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The same two individuals also subjectively graded the ability to identify the mucosal wall
layer. The mucosal wall layer was subjectively identified in each of the regions measured and
was graded using a scale previously described in the literature (Figure 2.3): 1 - good (defined as
a distinct mucosal surface); 2-moderate (defined as a visible but indistinct mucosal surface); and
3-poor (defined as no viewable difference between the mucosa and remainder of the
gastrointestinal wall).47

Figure 2.1

Maximal and minimal wall measurements

Demonstration of the measurements of the maximal and minimal wall thickness of the
descending duodenum during a portal phase of enhancement in a transverse plane of
reconstruction. Note the grade 2 mucosal enhancement.
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Figure 2.2

Figure 2.1

Demonstration of the maximal and minimal small intestinal diameter of the descending
duodenum in a venous phase of contrast enhancement in a transverse plane of reconstruction.
Note the grade 3 enhancement.
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Figure 2.3

Transverse plane of reconstruction of the descending duodenum

Example of the grading scheme for mucosal enhancement. Note the thing ring of enhancement
on the grade 1 image that progresses to the serosal surface in the grade 2 and grade 3 image
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Figure 2.4

Enhancement pattern of the normal canine descending duodenum

Note the grade 1 mucosal enhancement in the arterial and poral phases and grade 3 enhancement
in the venous phase. There is fluid attenuating material occupying approximately 95% of the
lumen. There is also a small mineral attenuating object within the gravity dependent portion of
the duodenal lumen.

Statistical methods
Analysis of small intestine diameter measurements in 30 dogs in three planes (transverse,
sagittal, and dorsal) with four phases was determined with linear mixed models using PROC
MIXED in SAS for Windows v9.4.10 Outcomes included three measurements for the duodenum

10

SAS Institute, Cary, NC
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(ascending, descending, and transverse), the average of three measurements in the jejunum, and
one measurement in the ileum. Measurements for each part of the small intestine included
minimum diameter, maximum diameter, minimum wall thickness, maximum wall thickness,
number of wall layers, and enhancement. Each dog’s small intestine was measured by two
investigators. The average of their measurements was used for further analysis. Separate models
were used for each plane for each measurement that had supporting data. Fixed effects included
phase, body weight, and the phase-body weight interaction. If the interaction term was not
significant, it was removed and the model refitted. Dog ID was included as a random effect.
Covariance structure in the model utilized that of variance components. Residual plots were used
to ensure the assumptions of normality and homoscedasticity had been met for the statistical
models. Significance of results was set at an alpha level of 0.05.
Study results
Study population results
During the study period, 30 dogs that met the inclusion parameters, were prospectively
enrolled and included in the study. No dogs were excluded from the study. All 30 dogs
underwent computed tomographic examination of the entire abdomen within the parameters
described. The most represented breed was mixed breed dogs with a total number of seven
included. Further breakdown of breeds included are as follows: mixed breed (7), Labrador
retriever (4), terrier (4), German shepherd Dog(3), goldendoodle (2), dachshund (2), boxer (2),
and one each of Pomeranian, Swiss mountain dog, Australian cattle dog, border collie, miniature
schnauzer, and English bulldog. There were 20 (67%) females and 10 (33%) males included in
the study. Of the 20 females included, 17 (85%) were spayed and three (15%) were intact. Of the
10 males included in the study, eight (80%) were neutered and two (20%) were intact. The
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maximum included weight was 55.8 kilograms and the minimum included weight was 4.4
kilograms, which resulted in a range of 51.4 kilograms. Overall eight dogs that weighed less than
15.20 kilograms, 13 dogs between 15.20 and 31.00 kilograms, and nine dogs greater than 31.00
kilograms were included. The median weight was 24.75 kilograms and the mean weight was
24.17 kilograms.
Transverse plane of reconstruction
Ascending duodenum
Patient weight had a significant effect on both the maximal (Figure 2.5) and minimal
(Figure 2.6) diameter of the ascending duodenum, with smaller dogs having significantly smaller
values than larger dogs. Significant effects between the maximal and minimal thickness of the
wall of the ascending duodenum and phase of enhancement, patient weight, nor weight and
phase of enhancement were not identified.
The phase of enhancement had a significant effect on the number of wall layers identified
(Error! Reference source not found.). Significantly more wall layers were identified in the
arterial and portal phases compared to the venous and noncontrast phases of enhancement, with
an average 1.900, 1.683, 1.466, and 1.333 wall layers being identified, respectively. No
significant difference was identified between either the arterial or portal nor between the venous
and noncontrast phases of enhancement.
A significant interaction between the degree of mucosal enhancement and body weight
and phase interaction was identified (Figure 2.15, Figure 2.16, Figure 2.17). In all groups, the
arterial phase had the greatest degree of mucosal enhancement, followed by the portal phase.
There was also a significant difference between the arterial and portal phases in relation to the
degree of mucosal enhancement with the arterial phase demonstrating greater significant
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enhancement in dogs less than 15.20 kilograms and 15.20 to 31.00 kilograms. There was no
significant difference between the arterial and portal phases in dogs greater than 31.00
kilograms. No significant effect was identified between the venous and noncontrast phases in any
weight group.

Figure 2.5

Maximal diameter of the ascending duodenum

Measurements from the noncontrast series were used for graph construction, as phase of
enhancement did not have a significant effect on diameter.
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Figure 2.6

Minimal diameter of the ascending duodenum

Measurements from the noncontrast series were used for graph construction, as phase of
enhancement did not have a significant effect on diameter.

Average number of wall layers
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Figure 2.7

Average number of wall layers identifed in the ascending duodenum identified in a
transverse plane of reconstruction

Note that the arterial and portal phases of contrast enhancement demonstrated the greatest
number of average wall layers identified.
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Descending duodenum
Patient weight had a significant effect on both the maximal (Error! Reference source
not found.) and minimal (Figure 2.9) diameter of the descending duodenum, with smaller dogs
having a significantly smaller diameter than larger dogs. Phase of enhancement did not affect the
overall diameter nor wall thickness. No significant association between patient weight and the
wall thickness of the descending duodenum (minimal or maximal) was identified.
Phase had a significant effect on the number of layers identified within the descending
duodenum (Figure 2.10). There were significantly more wall layers identified in both the arterial
and portal phases of enhancement compared to the venous and noncontrast phases, with an
average of 2.250 wall layers, 1.883 wall layers, 1.300 wall layers, and 1.267 wall layers being
identified respectively. There was no significant difference between the arterial and portal phases
or between the noncontrast and venous phases.
Both phase and the weight-phase interaction had a significant effect on the mucosal
enhancement of the descending duodenum (Figure 2.15, Figure 2.16, Figure 2.17). In all weight
classes the arterial phase demonstrated the greatest mucosal enhancement followed by the portal
phase. The greatest degree of mucosal enhancement was found in the arterial phase in dogs less
than 15.20 kilograms. The difference between the arterial and portal phases in regard to mucosal
enhancement, although not significant, was greatest in dogs less than 15.20 kilograms with dogs
weighing over 15.20 kilograms having relatively symmetric enhancement during these two
phases.
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Figure 2.8

Maximal diameter of the descending duodenum in a transverse plane of
reconstruction

Graphic demonstration of the positive association between patient body weight and maximal
diameter of the transverse duodenum in a transverse plane of reconstruction. The noncontrast
series was utilized for this graph, as the phase of contrast enhancement did not have an effect on
the measured diameter.

Figure 2.9

Minimal diameter of the descending duodenum in a transverse plane of
reconstruction

Graphic demonstration of the positive association between patient body weight and maximal
diameter of the descending duodenum in a transverse plane of reconstruction. The noncontrast
series was utilized for this graph, as the phase of contrast enhancement did not have an effect on
the measured diameter.
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Figure 2.10

Average number of wall layers identified in the descending duodenum in a
transvers plane of reconstruction

Note that the greatest average number of wall layers identified was in the arterial phase followed
by the portal phase.

Jejunum
Patient weight had a significant effect on the overall maximal (Figure 2.11) and minimal
(Error! Reference source not found.) diameter, with smaller dogs have significantly smaller
overall diameter than larger dogs. Patient weight, phase of enhancement, and patient weight and
phase of enhancement interaction did not have a significant effect on the maximal nor minimal
thickness of the wall.
Phase of enhancement had a significant effect on the number of wall layers identified
(Error! Reference source not found.) with the greatest average number of wall layers being
identified in the arterial phase (1.711), followed by the portal phase (1.494), then the venous
phase (1.306), and finally the noncontrast phase (1.206). There was also a significant difference
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between the arterial and portal phases, with significantly more wall layers identified in the
arterial phase. No significant difference was identified between the venous and noncontrast
phases of enhancement.
The phase of enhancement had a significant effect on the degree of mucosal enhancement
with a significantly greater degree of enhancement being identified in the arterial and portal
phases (Figure 2.15, Figure 2.16, Figure 2.17). No difference between these phases nor between
the venous and noncontrast phases was identified.

Figure 2.11

Maximal average jejunal diameter in a transverse plane of reconstruction

Graphic demonstration of the positive association between patient body weight and maximal
average diameter of the jejunum in a transverse plane of reconstruction. The noncontrast series
was utilized for this graph, as the phase of contrast enhancement did not have an effect on the
measured diameter.
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Figure 2.12

Average minimal jejunal diameter in a transverse plane of reconstruction

Graphic demonstration of the positive association between patient body weight and minimal
diameter of the jejunum in a transverse plane of reconstruction. The noncontrast series was
utilized for this graph, as the phase of contrast enhancement did not have an effect on the
measured diameter.
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Figure 2.13

Average number of wall layers identified in the jejunum in a transverse plane of
reconstruction

Note that the greatest average number of wall layers were identified within the arterial and portal
phases of enhancement.

Ileum
A significant interaction between phase of enhancement and both the number of wall
layers identified and the degree of mucosal enhancement were identified. A greater average
number of wall layers were identified in the portal phase (1.4833) followed by the arterial phase
(1.4333), then the venous phase (1.2500), and finally the noncontrast phase (1.0333).
Significantly more wall layers were identified on both the arterial and portal phases than in the
venous and noncontrast phases, with no significant difference between these two phases (Figure
2.14).
There was a significantly greater degree of mucosal enhancement in the portal phase
compared to the remaining phases of enhancement (Figure 2.15, Figure 2.16, Figure 2.17). There
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was no significant difference between the arterial phase and the venous phase nor between the
arterial phase and portal phase. The arterial phase had significantly greater mucosal enhancement
than the noncontrast series. There was also a significant difference in regard to the degree of
mucosal enhancement between the venous and noncontrast phases of enhancement, with a
greater degree of mucosal enhancement identified in the venous phase.
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Figure 2.14

Average number of wall layers identified in the ileum in a transverse plane of
reconstruction

Note that the greatest number of average wall layers was identified during the portal phase of
enhancement followed by the arterial phase of enhancement.
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Figure 2.15

Descending Duodenum
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Portal
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Avg Mucosal Enhacement Grade

Mucosal Enhancement, <15.2 kg

Ileum

Mucosal enhancement in dogs weighing less than 15.5 kilograms

Note that the greatest degree of mucosal enhancement occurred in the arterial and portal phases
for all segments. Also note that in the ileum the mucosal enhancement in the portal phase was
significantly better than that in the arterial phase of enhancement.

Figure 2.16
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Mucosal Enhancement, 15.2-31 kg
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Mucosal enhancement grade in dogs weighing between 15.5 kilograms and 31.0
kilograms

Note that the greatest degree of mucosal enhancement occurred in the arterial and portal phases
for all segments. Also note that in the ileum the mucosal enhancement in the portal phase was
significantly better than that in the arterial phase of enhancement.
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Figure 2.17
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Mucosal enhancement grade in dogs weighing greater than 31.0 kilograms

Note the greatest degree of mucosal enhancement occurred in both the arterial and portal phases
of enhancement. There was relatively symmetric mucosal enhancement in these two phases in all
segments except for the ileum, in which significantly better mucosal enhancement was identified
in the portal phase of enhancement than in the arterial phase.

Sagittal plane of reconstruction
Transverse Duodenum
In the transverse duodenum, weight had a significant effect on the maximal diameter,
with smaller dogs having a significantly smaller overall diameter (Figure 2.18, Error!
Reference source not found.). Phase of enhancement did not have a significant effect on either
the maximal or minimal diameter or wall thickness.
Phase of enhancement had a significant effect on the average number of wall layers
identified within the transverse duodenum with significantly more layers being identified in both
the arterial and portal phases (Figure 2.20). In the arterial phase of enhancement there was an
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average of 1.8833 wall layers identified and in a portal phase there was an average of 1.5833
wall layers identified.
Phase of enhancement also had a significant effect on the enhancement score of the
transverse duodenum with the arterial and portal phases having significantly greater mucosal
enhancement than the delayed venous and noncontrast series (Figure 2.15, Figure 2.16, Figure
2.17). No difference was identified between the arterial or portal phases. No significant
interactions between weight and minimal diameter, minimal and maximal wall thickness,
number of wall layers identified, and mucosal enhancement were identified.

Figure 2.18

Maximal Diameter of the transverse duodenum in a sagittal plane of reconstruction

Graphic demonstration of the positive association between patient body weight and maximal
diameter of the transverse duodenum in a sagittal plane of reconstruction. The noncontrast series
was utilized for this graph, as the phase of contrast enhancement did not have an effect on the
measured diameter.
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Figure 2.19

Minmal diameter of the transverse duodenum in a sagittal plane of reconstruction

Graphic demonstration of the positive association between patient body weight and minimal
diameter of the transverse duodenum in a sagittal plane of reconstruction. The noncontrast series
was utilized for this graph, as the phase of contrast enhancement did not have an effect on the
measured diameter.
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Figure 2.20

Average number of wall layers identified in the transverse duodenum in a sagittal
plane of reconstruction

Note that the greatest average number of wall layers identified occurred in the arterial phase.

Jejunum
In regard to the jejunum, significant interactions were found between weight and the
maximal (Error! Reference source not found.) and minimal (Figure 2.22) diameter, with
smaller dogs having an overall smaller diameter. No significant interactions between weight and
number of wall layers identified and degree of mucosal enhancement were identified. A
significant interaction between phase of enhancement and the minimal jejunal wall thickness was
identified.
A significant effect between phase of enhancement and average number of wall layers
was also identified with the arterial and portal phases having significantly more wall layers
identified, 1.600 and 1.5556 respectively (Figure 2.23).
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Significant interactions between both weight and phase of enhancement and degree of
mucosal enhancement were also found (Figure 2.15, Figure 2.16, Figure 2.17). In all weight
groups (dogs less than 15.20 kilograms, between 15.21 kilograms and 31.00 kilograms, and those
over 31 kilograms, the arterial and portal phases had the greatest degree of enhancement. No
difference was identified between these two phases or between the delayed venous phase and the
noncontrast series. In dogs over 31 kilograms, better mucosal enhancement was identified in the
portal phase than in the arterial phase; however, this was not significant.

Figure 2.21

Average maximal overall jejunal diameter in a sagittal plane of reconstruction

Graphic demonstration of the positive association between patient body weight and maximal
diameter of the jejunum in a sagittal plane of reconstruction. The noncontrast series was utilized
for this graph as phase of enhancement did not have a significant effect on maximal diameter.
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Figure 2.22

Figure 2.21 diameter in a sagittal plane of reconstruction

Graphic demonstration of the positive association between patient body weight and maximal
diameter of the jejunum in a sagittal plane of reconstruction. The noncontrast series was utilized
for this graph as phase of enhancement did have a significant effect on minimal diameter.
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Figure 2.23

Average number of wall layers (averaged) identified in the jejunum in a sagittal
plane of reconstruction

Note the greatest average number of wall layers was slightly higher in the arterial phase than in
the portal phase of contrast enhancement. However, these two phases of contrast enhancement
were similar.

Dorsal plane of reconstruction
Jejunum
Patient weight had a significant effect on the maximal diameter of the jejunum, with
smaller dogs have an overall smaller diameter (Figure 2.24). An interaction between weight and
minimal diameter was not identified in the jejunum. Patient weight nor phase of enhancement
had an effect on the maximal and minimal jejunal wall thickness.
A significant interaction between phase of enhancement and average number of wall
layers within the jejunum was identified, with more layers being identified in the arterial and
portal phases than in the delayed venous and noncontrast phases (Figure 2.25). The most layers
were identified within the portal phase (1.5944) followed by the arterial phase (1.5722).
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Significant interactions were identified between both weight and phase and degree of
jejunal mucosal contrast enhancement (Figure 2.15, Figure 2.16, Figure 2.17). For dogs 15.20
kilograms and less, the arterial phase had the greatest degree of mucosal enhancement. For dogs
greater than 15.20 kilograms, the portal phase had the greatest degree of mucosal enhancement.
For all weight groups, the arterial and portal phases had greater degrees of mucosal enhancement
with no significant difference between these two groups. A significant difference was also not
identified between the delayed venous and noncontrast series in regard to degree of mucosal
enhancement.

Figure 2.24

Maximal overall average jejunal diameter in a dorsal plane of reconstruction

Graphic demonstration of the positive association between patient body weight and maximal
diameter of the jejunum in a dorsal plane of reconstruction. The noncontrast series was utilized
for this graph as phase of enhancement did not have a significant effect on maximal diameter.
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Figure 2.25

Average number of wall layers identified in the jejunum in a dorsal plane of
reconstruction

The greatest average number of wall layers occurred within the arterial and portal phases of
enhancement. Note that these two phases of enhancement demonstrated a similar number of wall
layers identified.

In a dorsal plane of reconstruction, measurements were not obtained from the duodenum
(any portion) or ileum, as these segments of the small intestine had their long axes oriented with
the plane of reconstruction.
Subjective evaluation
In the author’s opinion, the transverse plane was the most useful plane to identify each
segment of small intestine measured. This is due to the perpendicular orientation of the majority
of gastrointestinal tract to this plane of reconstruction. This orientation demonstrated the greatest
number of small intestinal segments in cross section. Additional patient comorbidities that made
it difficult to measure the small intestine were peritoneal effusion, which occurred in 2 dogs, and
a thin body condition, which occurred in one dog. Increasing patient weight made identifying
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and measuring each segment of small intestine subjectively easier. The presence of ingesta made
measuring the overall diameter easier on all phases and the wall thickness easier on the
postcontrast phases (arterial, portal, and venous). However, the presence of ingesta made it more
difficult to measure wall thickness on the noncontrast series. The position of the patient during
scanning (dorsal or ventral recumbency) did not subjectively have an effect on the ability to
measure either the wall thickness or overall diameter of the small intestinal tract.
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CHAPTER III
DISCUSSION
Discussion
The author was able to accept the first hypothesis in that the arterial phase in the majority
of the small bowel segments demonstrated the greatest mucosal enhancement. In dogs less than
31.00 kilograms and in a transverse plane of reconstruction, the arterial phase demonstrated a
significantly greater degree of enhancement in the ascending duodenum than the portal phase. In
the remaining portions of the small bowel segments and for all weight groups the degree of
enhancement in the arterial phase was not significantly greater than the degree of enhancement in
the portal phase. However, for all weight classes in the ileum in a transverse plane of
reconstruction, for the jejunum in a sagittal plane of reconstruction in dogs greater than 15.20
kilograms, and for the jejunum in a dorsal plane of reconstruction for dogs greater than 15.20
kilograms, the portal phase demonstrated the greatest degree of mucosal enhancement followed
closely by the arterial phase, although the differences between these two phases were again not
significant.
The degree of mucosal enhancement seen within the arterial phase is likely due to the
vascular supply to the different layers of the canine small bowel. A prior study91 by Delaney and
colleagues showed that the canine small intestine receives approximately 6.48% of the cardiac
output. The blood flow within the duodenum has been shown to be approximately 0.70 mL/min-
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g of tissue while the remaining small intestinal tract has been shown to have a flow 0.72
mL/min-g of tissue.
The blood supply within the intestines is quite complex and is composed of two different
parallel capillary beds: the mucous-submucous and muscular-serous plexi.37,92 The arterial
supply enters the mesenteric border through the serosal layer and arborizes in several splanchnic
branches before entering the muscularis layering and forming a vast plexus within the
submucosa. Two groups of arteries then exit the submucosa with one group giving off branches
that surrounds the glands lining the crypt cells and the other continuing to course to the villi
within the mucosa.93 A larger portion of resting blood flow within the canine intestinal tract ends
up within the mucosal and submucosal layers. In fact, 5-33% of blood flow within these two
layers ends up within the submucosa, while 24-37% ends up in the mucosal villi and 21-27% end
up in the intestinal crypts.93 In the dog, approximately 65-92% of the blood flow to the small
intestines ends up within the mucosa-submucosa plexus, while 8-35% ends up within the
muscularis-serosa plexus. This distribution is similar to a feline model in which 62-85% was
distributed to the mucosa-submucosa plexus, and 15-38% distributed to the muscularis-serosa
plexus.93–95
The timing of the scan delays also likely played a role in this finding. A prior study25 has
described the arterial phase of enhancement occurring 5-10 seconds after initiation of injection
and a portal phase of enhancement occurring 25-40 seconds after initiation of injection. Our
arterial phase was defined as 25 seconds after initiation of injection and our portal phase was
defined as 45 seconds after initiation of injection. These time points were selected due to
technical parameters dealing with tube heat loading and cooling, scan parameter adjustments,
and the fact that our patients were primarily undergoing computed tomography for a body region
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not associated with the abdomen. The arterial phase of enhancement for the body region
associated with the primary cause of scanning was preferentially acquired approximately 10
seconds after initiation of injection. After this acquisition was obtained, the CT scan parameters
were reset and the abdomen was acquired in three sequential scans. This lack of a true arterial
phase and instead acquisition during the early and late phases of the portal period of
enhancement likely affected our results.
In addition, a prior study48 performed in dogs found that the greatest degree of mucosal
enhancement was observed approximately 38 seconds after initiation of contrast injection. In this
study, a new phase of contrast enhancement of the canine small bowel was described and termed
the intestinal phase. This phase is defined as the peak enhancement of the intestinal wall and
occurred at 38.0 ± 4.2 s after initiation of injection. During this phase there was distinct
enhancement of the intestinal wall, as well as, a distinguishable mucosal layer. This study
however, did not find a difference between the enhancement of the intestinal wall in this phase
compared to an early venous phase (55.3 ± 3.5 s after initiation of injection).48 This study also
did not attempt to evaluate the small intestines during a true arterial phase. The timing of this
intestinal phase falls within the portal period of enhancement as previously described25, so it is
the author’s opinion that this new term of enhancement is a simple misnomer for the previously
described portal period. However, similar to our study, the study48 by Lee and colleagues found
that during the intestinal phase (portal period), the innermost layer of the intestinal wall was
enhanced more than the remaining wall and the wall became more homogeneously enhanced on
the venous phase. In fact, in this prior study, 22 out of 33 intestinal segments had distinct
contrast enhancement in the innermost layer, which the authors described as the mucosa and
submucosa.
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A reason for the mucosal enhancement being greater in the portal phase in the ileum is
not clear. However, it likely corresponds to the vascular supply to the ileum as well as the
thickness of the mucosal layer in this segment. The ileum is the terminal segment of the
intestinal tract and derives its blood supply from the terminal branches of the cranial mesenteric
artery. The jejunum is also histologically composed of much denser tissue and contains a greater
proportion of mucosal tissue than the ileum.96 This study demonstrated that the jejunum is made
up of approximately 82% mucosa, while the ileum only contains approximately 76% mucosa.
There are also differences in the mucosal villi within these two segments with the jejunal
mucosal villi having longer and wider villi, deeper crypts, and taller enterocytes than the ileal
mucosal villi.96 The jejunal villi are also more tightly packed than the ileal villi, which may have
contributed to the increased conspicuity of the jejunal wall layer on the arterial phase.97 The
decrease in mucosal tissue and its associated vascular networks within the ileum likely resulted
in a decrease in the identifiable contrast enhancement within this layer on the arterial phase. The
ileum also has a thicker muscularis layer, which may be the layer identified on the portal phase
of enhancement.34 However, this finding needs to be verified with histopathology of full
thickness biopsies.
An interesting finding in this current study is the thin, strongly contrast enhancing rim
within the arterial phase in multiple segments of the small bowel. The grading system employed
in this study was adapted from a prior study by Fitzgerald et al.47 In that study, a thin rim of
contrast enhancement within the inner most layer of the gastrointestinal tract was determined to
be grade 1 mucosal enhancement and was thought to represent enhancement of only the mucosal
layer. However, a prior study40 using ultrasonography identified that the mucosal layer within the
duodenum and jejunum is significantly thicker than the remaining layers, typically in the range
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of being as thick as the remaining layers combined. The mucosal layer within the duodenum and
jejunum in that set of dogs contributed to 63-64% and 57-60% of the overall wall thickness in
those segments, respectively. Weight also had a significant effect on mucosal thickness, with
smaller dogs having a thinner mucosal layer in both the duodenum and jejunum as compared to
larger dogs. A significant difference between the remaining three layers was not identified.40 A
more recent ex vivo ultrasonographic study19 also identified a dual echogenicity within the
mucosal layer of the small intestines in normal dogs. The authors in this study19 attributed this
inner most hyperechoic layer to lacteal dilation within the tip of the intestinal villi. Given these
studies, the inclusion of only clinically normal dogs in the present study, and the rich vascular
network within the intestinal villi, the author proposes that this thin rim of enhancement during
the arterial phase in the current study may in fact represent enhancement within the intestinal
villi specifically as opposed to enhancement of the entire mucosal layer. In order to confirm this,
full thickness biopsies followed by histopathology would be needed. This was not performed in
the current study due to ethical constraints. If this thin contrast enhancing layer does represent
the mucosal villi, then future work could be performed to determine if this layer becomes
thickened or enlarged in dogs with lymphangiectasia.
The author was able to accept the second hypothesis in that body weight was positively
correlated with small intestinal diameter. In the transverse plane of reconstruction, patient weight
was positively correlated with both the maximal and minimal diameter of each segment of the
small bowel. In a dorsal and sagittal plane of reconstruction, only the maximal small intestinal
diameter was affected by patient body weight, with smaller dogs have significantly smaller
overall diameters. The significance of this finding is hard to interpret, as no attempt was made to
ensure that dogs had been fasted or feed the same amount of food prior to imaging. This
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limitation may alter the significance of this finding as dogs that had been fed shortly prior to
imaging would likely have had an overall greater diameter than those that had been fasted or not
been fed recently. The clinical significance of this finding is also difficult to interpret. A prior
study28 has shown that computed tomography is 100% sensitive and specific for the diagnosis of
a small intestinal mechanical obstruction, while ultrasound had a sensitivity of 100% and
specificity of 67%. In this study a ratio of the largest intestinal diameter to smallest intestinal
diameter of greater than 4.0 was consistent with a mechanical obstruction.28 In other studies
using abdominal radiography, multiple ratios have been proposed to identify cases with
mechanical obstruction. Some of these ratios use the central height of the L5 vertebral body and
range from 1.6 to 2.4, while others found a ratio of the maximal small intestinal diameter to
minimal small intestinal diameter ≥3.4 and a ratio of the maximal small intestinal diameter to the
average small intestinal diameter ≥1.9 were likely obstructed.28,98–100 Ultrasonographically, a
jejunal diameter >1.5 cm has been associated with small intestinal obstruction.98 Given that
ratios of the largest and smallest diameter were not performed in this study, the positive
correlation between body weight and small intestinal diameter should be interpreted cautiously.
The hypothesis that intestinal wall thickness would be correlated to body weight was
rejected for all segments of small bowel in all planes of reconstruction and all phases of contrast
enhancement. This is in contrast to a prior ultrasonographic study41, which demonstrated a
positive correlation between body weight and duodenal and jejunal wall thickness. In that study
both the duodenal and jejunal wall thicknesses was significantly greater in large dogs than in
small dogs with the jejunum in small dogs being ≤4.4 mm and in large dogs ≤4.7 mm, while the
duodenum in small dogs was ≤5.1 mm and in larger dogs it was ≤6.0 mm. A separate study40
also showed that the thickness of the mucosal layer was also positively correlated with body
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weight. In that study, small dogs had a mean jejunal mucosal thickens of 1.8 ± 0.4 mm, while
large dogs had a thickness of 2.2 ± 0.5 mm. The duodenal mucosal thickness in this study for
small dogs was 2.4 ± 0.5 mm, while in large dogs it was 2.8 ± 0.5 mm. It is not clear why a
similar result was not found in this study. One possibility is that an insufficient number of dogs
were sampled. Another possibility is the limitation of decreased spatial resolution using
computed tomography compared to that of ultrasound.
The author was also able to accept the fourth hypothesis. The addition of arterial and
portal phases resulted in significantly more wall layers being identified in these two phases than
in the noncontrast and venous phases. This hypothesis held true for all segments of small bowel
in all planes of reconstruction. The reason for this is also unclear. Prior studies42,101 have been
performed in both feline and canine patients using contrast enhanced ultrasonography that have
identified the normal vascular pattern within the normal intestinal wall in both of these species.
The vascular pattern within the canine intestinal wall has been described as a typical serosal to
luminal enhancement direction, with radial enhancement of the jejunal wall also identified. No
difference between the ingress and egress time between the mesenteric and antimesenteric sides
of the small bowel was identified in this canine model.42 In cats, the typical pattern of
enhancement using contrast ultrasonography has been described as an initial rapid enhancement
of the serosal and submucosal layers, which was followed by gradual enhancement of the entire
wall. The washout phase was gradual, and the submucosal layer was the last to washout. During
peak enhancement, the authors within this paper could identify the different wall layering.101 One
cause for the discrepancy between what was identified on contrast enhance ultrasound and this
study is the improved spatial resolution of ultrasound compared to computed tomography. Given
that ultrasound has increased spatial resolution as compared to CT, the smaller vessels within the
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serosal layer are likely easier to identify on ultrasound compared to CT. The larger plexus within
the mucosa and submucosa may also be easier to identify on CT, given its better contrast
resolution as compared to ultrasound.
Lastly, the authors subjectively identified the transverse plane of reconstruction as the
most useful plane of reconstruction for quantification of the canine small bowel. This is due to
the orientation of the canine small bowel with the three planes of reconstruction: transverse,
sagittal, and dorsal. The duodenum, for the most part, runs in a line parallel to the right lateral
abdominal body, hindering the evaluation of it in cross-section on either the sagittal or dorsal
planes. The ileum also lies in a plane that is parallel to the long axis of the abdominal cavity,
which also hinders evaluation of it in cross section on both the sagittal and dorsal planes. The
jejunum takes a more serpentine course through the abdominal cavity, which allows portions of
it to be evaluated in almost any plane of reconstruction. Two prior studies have reported
identification rates of 77% and 84.5% of a segment of the gastrointestinal tract in its transverse
plane of reconstruction.46,47
Limitations
There were a number of limitations within this study. The first and most significant
limitation is the lack of comparison between the obtained CT measurements and the gold
standard imaging modality, ultrasound. The reasons for not pursuing this comparison are
numerous, with the largest contributors being financial and clinical time constraints. Another
major limitation of this study is the lack of histopathologic confirmation of normalcy for dogs
included. However, in order to determine normalcy, histopathology of full or partial
gastrointestinal biopsies would be required, and this procedure is neither benign nor ethical in
clinically unaffected patients. This absence of histopathology may have allowed for the inclusion
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of dogs with subclinical gastrointestinal disease. However, attempts were made to ensure that
included patients had no abnormalities that could affect the gastrointestinal tract, including
serum chemistry, clinical history, and a thorough physical exam.
Another limitation is that a standardized sedation protocol was not utilized. This was
done to mimic a clinical setting and to make the obtained data more clinically applicable.
Different sedatives affect the appearance and function of the small intestine differently.
Specifically, administration of -2 and opiate agonists have been shown to cause gastrointestinal
stasis by increasing gastrointestinal sphincter tones and intestinal segmental tone, thereby
causing functional ileus, which may lead to a falsely increased small intestinal diameter.102
Additionally, patient parameters that may affect contrast distribution, such as cardiac output,
systemic vascular resistance, and respiratory rate were not consistently monitored during the
examinations.103–105 The requirement for monitoring sedated patient parameters at the authors’
institution is to record heart and respiratory rates every 5 minutes under sedation. Given that the
majority of these computed tomographic examinations took between 5-10 minutes only a single
monitoring event took place. The variability in sedative drug choice and dosing is also a
confounding factor that likely contributed to the variability in patient parameters that affect
contrast distribution.
Lastly, patient positioning (i.e., all in either sternal or dorsal recumbency) was not
consistent. This was due to the inclusion of the abdomen as an additional site and not the
patient’s primary reason for imaging. The positioning of all patients was dictated by the optimal
positioning for investigation of the anatomy related to the clinical problem. Respiratory induced
motion has been shown to have a significant effect on evaluation of abdominal viscera in both
sternal and dorsal recumbency.106 This motion has also been shown to have differing effects on
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the CT evaluation of abdominal viscera with less respiratory motion found within the liver and
urinary bladder in sternal recumbency than in dorsal. In the remaining abdominal organs, dorsal
recumbency was the optimal patient positioning.106
Future Studies
Future studies should be performed to compare measurements obtained on computed
tomography and the gold standard of ultrasound, to determine if these two modalities show a
degree of correlation. Additionally, the correlation between the identification and measurements
of individual small bowel layers in dogs and histopathology of full thickness small bowel
biopsies should be investigated. Given that all of the included dogs within this study were
normal, future studies should also be performed in a subset of dogs effected with disease
processes that have been shown to alter the small bowel wall thickness, such as inflammatory
bowel disease, lymphangiectasia, neoplastic etiologies, and/or infectious etiologies.
Synopsis
This study identified that the addition of arterial and portal phases of contrast
enhancement during computed tomography aided in the identification and evaluation of the wall
layering, diameter, and thickness of the normal canine small bowel. Specifically, these two
phases demonstrated the greatest degree of mucosal enhancement as well as the greatest number
of wall layers identified. In addition, the overall small bowel diameter is positively correlated
with patient weight, but small bowel wall thickness was not affected by patient weight. In this
study, the transverse plane of reconstruction was the most useful plane when quantifying the
thickness and overall diameter of the canine small bowel. The author recommends the inclusion
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of both an arterial and portal phase when utilizing computed tomography angiography to
evaluate the canine small bowel.
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